🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ziyou Cui

Eureka Therapeutics (United States)

ORCID: 0000-0002-4002-2509

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition”.

Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition

Frontiers in Immunology(2021)10.3389/fimmu.2021.663379

N/A

0DataRank · unranked

37 citations

Thapi D. Rao, Ian Laster, A. P. Kononenko, Terence J. Purdon, Pei Wang +5 more

Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma

Scientific Reports(2022)10.1038/s41598-022-15946-5

N/A

0DataRank · unranked

18 citations

Hong Liu, Moumita Dasgupta, Lance M. Hellman, Xiaogang Zhang, Hui Xue +13 more

A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML

Blood(2023)10.1182/blood.2023021054

N/A

0DataRank · unranked

27 citations

Guangyan Xiong, Sung Soo Mun, Jeremy Meyerberg, Tatyana Korontsvit, J Xiang +14 more